NCT07391319: The Prospective, Double-blind, Multicenter, Placebo-controlled, Randomized, Comparative Clinical Trial
- State
- Under way
- Phase
- Phase 3
- People
- 144 planned
- Started
- 11 Feb 2025
- Primary completion
- 31 Mar 2027
- Arms
- The investigational therapy group (Neovasculgen)
- Results
- None posted
- 11 Feb 2025: Trial started
- 5 Feb 2026: Trial registered